FDA Inspection 915574 — Onelegacy
The FDA completed an inspection of Onelegacy on February 19, 2015 in Bakersfield, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 19, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bakersfield, CA (United States)